SCOPUS 정보 검색 플랫폼

Volumn 212, Issue 13, 2015, Pages 2189-2201

Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy

(11) Kelly, Priscilla N a Romero, Donna L b Yang, Yibin a Shaffer, Arthur L a Chaudhary, Divya b Robinson, Shaughnessy c Miao, Wenyan b Rui, Lixin a,d Westlin, William F b Kapeller, Rosana b Staudt, Louis M a

a NATIONAL CANCER INSTITUTE (United States)

b Nimbus Therapeutics (United States)

c SCHRÖDINGER INC (United States)

d UNIVERSITY OF WISCONSIN MADISON (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCL2 RELATED PROTEIN A1; CD79A ANTIGEN; CD79B ANTIGEN; IBRUTINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4 INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6; JANUS KINASE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; ND 2110; ND 2158; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VENETOCLAX; AGAMMAGLOBULINAEMIA TYROSINE KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK4 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KINASE INHIBITOR; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; SYK PROTEIN, HUMAN; SYK PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENTIATION; GENE EXPRESSION; LARGE CELL LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL DEATH; CHEMISTRY; DBA MOUSE; DRUG DEVELOPMENT; DRUG EFFECTS; GOUT; HUMAN; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; CELL DEATH; CELL LINE, TUMOR; DRUG DISCOVERY; GOUT; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MICE, INBRED BALB C; MICE, INBRED DBA; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SYK KINASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84961226444 PISSN: 00221007 EISSN: 15409538 Source Type: Journal
DOI: 10.1084/jem.20151074 Document Type: Article

Times cited : (143)

References (44)

1
- 0034598746
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
- Alizadeh, A.A., M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, T. Tran, X. Yu, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:503-511. http://dx.doi.org/10.1038/35000501
- (2000) Nature. , vol.403 , pp. 503-511
- Alizadeh, A.A.¹ Eisen, M.B.² Davis, R.E.³ Ma, C.⁴ Lossos, I.S.⁵ Rosenwald, A.⁶ Boldrick, J.C.⁷ Sabet, H.⁸ Tran, T.⁹ Yu, X.¹⁰

2
- 0001736325
- Animal models of rheumatoid arthritis
- Bendele, A. 2001. Animal models of rheumatoid arthritis. J. Musculoskelet. Neuronal Interact. 1:377-385.
- (2001) J. Musculoskelet. Neuronal Interact. , vol.1 , pp. 377-385
- Bendele, A.¹

3
- 16644371648
- The mouse model of collagen-induced arthritis
- Brand, D.D., A.H. Kang, and E.F. Rosloniec. 2004. The mouse model of collagen-induced arthritis. Methods Mol. Med. 102:295-312.
- (2004) Methods Mol. Med. , vol.102 , pp. 295-312
- Brand, D.D.¹ Kang, A.H.² Rosloniec, E.F.³

4
- 84905641032
- Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors
- Ceribelli, M., P.N. Kelly, A.L. Shaffer, G.W. Wright, W. Xiao, Y. Yang, L.A. Mathews Griner, R. Guha, P. Shinn, J.M. Keller, et al. 2014. Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors. Proc. Natl. Acad. Sci. USA. 111:11365-11370. http://dx.doi.org/10.1073/pnas.1411701111
- (2014) Proc. Natl. Acad. Sci. USA. , vol.111 , pp. 11365-11370
- Ceribelli, M.¹ Kelly, P.N.² Shaffer, A.L.³ Wright, G.W.⁴ Xiao, W.⁵ Yang, Y.⁶ Mathews Griner, L.A.⁷ Guha, R.⁸ Shinn, P.⁹ Keller, J.M.¹⁰

5
- 84920964273
- Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptorassociated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders
- Chaudhary, D., S. Robinson, and D.L. Romero. 2015. Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptorassociated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders. J. Med. Chem. 58:96-110. http://dx.doi.org/10.1021/jm5016044
- (2015) J. Med. Chem. , vol.58 , pp. 96-110
- Chaudhary, D.¹ Robinson, S.² Romero, D.L.³

6
- 33746747096
- MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals
- Chen, C.J., Y. Shi, A. Hearn, K. Fitzgerald, D. Golenbock, G. Reed, S. Akira, and K.L. Rock. 2006. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116:2262-2271. http://dx.doi.org/10.1172/JCI28075
- (2006) J. Clin. Invest. , vol.116 , pp. 2262-2271
- Chen, C.J.¹ Shi, Y.² Hearn, A.³ Fitzgerald, K.⁴ Golenbock, D.⁵ Reed, G.⁶ Akira, S.⁷ Rock, K.L.⁸

7
- 33845316120
- Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop
- Cheng, H., T. Addona, H. Keshishian, E. Dahlstrand, C. Lu, M. Dorsch, Z. Li, A. Wang, T.D. Ocain, P. Li, et al. 2007. Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop. Biochem. Biophys. Res. Commun. 352:609-616. http://dx.doi.org/10.1016/j.bbrc.2006.11.068
- (2007) Biochem. Biophys. Res. Commun. , vol.352 , pp. 609-616
- Cheng, H.¹ Addona, T.² Keshishian, H.³ Dahlstrand, E.⁴ Lu, C.⁵ Dorsch, M.⁶ Li, Z.⁷ Wang, A.⁸ Ocain, T.D.⁹ Li, P.¹⁰

8
- 0037450737
- Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by tolllike receptor 4 signaling
- Choe, J.Y., B. Crain, S.R. Wu, and M. Corr. 2003. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by tolllike receptor 4 signaling. J. Exp. Med. 197:537-542. http://dx.doi.org/10.1084/jem.20021850
- (2003) J. Exp. Med. , vol.197 , pp. 537-542
- Choe, J.Y.¹ Crain, B.² Wu, S.R.³ Corr, M.⁴

9
- 76549129820
- Drug combination studies and their synergy quantification using the Chou-Talalay method
- Chou, T.C. 2010. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70:440-446. http://dx.doi.org/10.1158/0008-5472.CAN-09-1947
- (2010) Cancer Res. , vol.70 , pp. 440-446
- Chou, T.C.¹

10
- 84856023801
- Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis
- Coffey, G., F. DeGuzman, M. Inagaki, Y. Pak, S.M. Delaney, D. Ives, A. Betz, Z.J. Jia, A. Pandey, D. Baker, et al. 2012. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis. J. Pharmacol. Exp. Ther. 340:350-359. http://dx.doi.org/10.1124/jpet.111.188441
- (2012) J. Pharmacol. Exp. Ther. , vol.340 , pp. 350-359
- Coffey, G.¹ DeGuzman, F.² Inagaki, M.³ Pak, Y.⁴ Delaney, S.M.⁵ Ives, D.⁶ Betz, A.⁷ Jia, Z.J.⁸ Pandey, A.⁹ Baker, D.¹⁰

11
- 84939963296
- IRAK inhibitors and uses thereof
- Google patent publication number WO2012097013 A1. Available at, accessed June 10
- Corin, A.F., L.L. Frye, J.R. Greenwood, G.C. Harriman, C. Masse, S. Robinson, D.L. Romero, K.S. Watts, and M.D. Wessel 2012 IRAK inhibitors and uses thereof. Google patent publication number WO2012097013 A1. Available at: http://www.google.com/patents/WO2012097013A1 (accessed June 10, 2015).
- (2012)
- Corin, A.F.¹ Frye, L.L.² Greenwood, J.R.³ Harriman, G.C.⁴ Masse, C.⁵ Robinson, S.⁶ Romero, D.L.⁷ Watts, K.S.⁸ Wessel, M.D.⁹

12
- 73849145729
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- Davis, R.E., V.N. Ngo, G. Lenz, P. Tolar, R.M. Young, P.B. Romesser, H. Kohlhammer, L. Lamy, H. Zhao, Y. Yang, et al. 2010. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 463:88-92. http://dx.doi.org/10.1038/nature08638
- (2010) Nature. , vol.463 , pp. 88-92
- Davis, R.E.¹ Ngo, V.N.² Lenz, G.³ Tolar, P.⁴ Young, R.M.⁵ Romesser, P.B.⁶ Kohlhammer, H.⁷ Lamy, L.⁸ Zhao, H.⁹ Yang, Y.¹⁰

13
- 33645076274
- TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE
- Ehlers, M., H. Fukuyama, T.L. McGaha, A. Aderem, and J.V. Ravetch. 2006. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 203:553-561. http://dx.doi.org/10.1084/jem.20052438
- (2006) J. Exp. Med. , vol.203 , pp. 553-561
- Ehlers, M.¹ Fukuyama, H.² McGaha, T.L.³ Aderem, A.⁴ Ravetch, J.V.⁵

14
- 84907975948
- IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly
- Ferrao, R., H. Zhou, Y. Shan, Q. Liu, Q. Li, D.E. Shaw, X. Li, and H. Wu. 2014. IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly. Mol. Cell. 55:891-903. http://dx.doi.org/10.1016/j.molcel.2014.08.006
- (2014) Mol. Cell. , vol.55 , pp. 891-903
- Ferrao, R.¹ Zhou, H.² Shan, Y.³ Liu, Q.⁴ Li, Q.⁵ Shaw, D.E.⁶ Li, X.⁷ Wu, H.⁸

15
- 79953162780
- Toll-like receptor driven B cell activation in the induction of systemic autoimmunity
- Green, N.M., and A. Marshak-Rothstein. 2011. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin. Immunol. 23:106-112. http://dx.doi.org/10.1016/j.smim.2011.01.016
- (2011) Semin. Immunol. , vol.23 , pp. 106-112
- Green, N.M.¹ Marshak-Rothstein, A.²

16
- 80052181600
- Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif
- Jurk, M., G. Chikh, B. Schulte, A. Kritzler, D. Richardt-Pargmann, C. Lampron, R. Luu, A.M. Krieg, A.P. Vicari, and J. Vollmer. 2011. Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif. Nucleic Acid Ther. 21:201-214. http://dx.doi.org/10.1089/nat.2011.0298
- (2011) Nucleic Acid Ther. , vol.21 , pp. 201-214
- Jurk, M.¹ Chikh, G.² Schulte, B.³ Kritzler, A.⁴ Richardt-Pargmann, D.⁵ Lampron, C.⁶ Luu, R.⁷ Krieg, A.M.⁸ Vicari, A.P.⁹ Vollmer, J.¹⁰

17
- 0033166472
- Unresponsiveness of MyD88-deficient mice to endotoxin
- Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:115-122. http://dx.doi.org/10.1016/S1074-7613(00)80086-2
- (1999) Immunity. , vol.11 , pp. 115-122
- Kawai, T.¹ Adachi, O.² Ogawa, T.³ Takeda, K.⁴ Akira, S.⁵

18
- 34249078495
- A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity
- Kim, T.W., K. Staschke, K. Bulek, J. Yao, K. Peters, K.H. Oh, Y. Vandenburg, H. Xiao, W. Qian, T. Hamilton, et al. 2007. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 204:1025-1036. http://dx.doi.org/10.1084/jem.20061825
- (2007) J. Exp. Med. , vol.204 , pp. 1025-1036
- Kim, T.W.¹ Staschke, K.² Bulek, K.³ Yao, J.⁴ Peters, K.⁵ Oh, K.H.⁶ Vandenburg, Y.⁷ Xiao, H.⁸ Qian, W.⁹ Hamilton, T.¹⁰

19
- 84885337075
- High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
- Kraan, W., H.M. Horlings, M. van Keimpema, E.J. Schilder-Tol, M.E. Oud, C. Scheepstra, P.M. Kluin, M.J. Kersten, M. Spaargaren, and S.T. Pals. 2013. High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites. Blood Cancer J. 3:e139. http://dx.doi.org/10.1038/bcj.2013.28
- (2013) Blood Cancer J. , vol.3 , pp. e139
- Kraan, W.¹ Horlings, H.M.² Van Keimpema, M.³ Schilder-Tol, E.J.⁴ Oud, M.E.⁵ Scheepstra, C.⁶ Kluin, P.M.⁷ Kersten, M.J.⁸ Spaargaren, M.⁹ Pals, S.T.¹⁰

20
- 84895814292
- High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma
- Kraan, W., M. van Keimpema, H.M. Horlings, E.J. Schilder-Tol, M.E. Oud, L.A. Noorduyn, P.M. Kluin, M.J. Kersten, M. Spaargaren, and S.T. Pals. 2014. High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma. Leukemia. 28:719-720. http://dx.doi.org/10.1038/leu.2013.348
- (2014) Leukemia. , vol.28 , pp. 719-720
- Kraan, W.¹ Van Keimpema, M.² Horlings, H.M.³ Schilder-Tol, E.J.⁴ Oud, M.E.⁵ Noorduyn, L.A.⁶ Kluin, P.M.⁷ Kersten, M.J.⁸ Spaargaren, M.⁹ Pals, S.T.¹⁰

21
- 19944428834
- Small molecule inhibitors of IκB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling
- Lam, L.T., R.E. Davis, J. Pierce, M. Hepperle, Y. Xu, M. Hottelet, Y. Nong, D. Wen, J. Adams, L. Dang, and L.M. Staudt. 2005. Small molecule inhibitors of IκB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin. Cancer Res. 11:28-40.
- (2005) Clin. Cancer Res. , vol.11 , pp. 28-40
- Lam, L.T.¹ Davis, R.E.² Pierce, J.³ Hepperle, M.⁴ Xu, Y.⁵ Hottelet, M.⁶ Nong, Y.⁷ Wen, D.⁸ Adams, J.⁹ Dang, L.¹⁰ Staudt, L.M.¹¹

22
- 43549097394
- Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma
- Lam, L.T., G. Wright, R.E. Davis, G. Lenz, P. Farinha, L. Dang, J.W. Chan, A. Rosenwald, R.D. Gascoyne, and L.M. Staudt. 2008. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma. Blood. 111:3701-3713. http://dx.doi.org/10.1182/blood-2007-09-111948
- (2008) Blood. , vol.111 , pp. 3701-3713
- Lam, L.T.¹ Wright, G.² Davis, R.E.³ Lenz, G.⁴ Farinha, P.⁵ Dang, L.⁶ Chan, J.W.⁷ Rosenwald, A.⁸ Gascoyne, R.D.⁹ Staudt, L.M.¹⁰

23
- 27744444832
- RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement
- Lau, C.M., C. Broughton, A.S. Tabor, S. Akira, R.A. Flavell, M.J. Mamula, S.R. Christensen, M.J. Shlomchik, G.A. Viglianti, I.R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202:1171-1177. http://dx.doi.org/10.1084/jem.20050630
- (2005) J. Exp. Med. , vol.202 , pp. 1171-1177
- Lau, C.M.¹ Broughton, C.² Tabor, A.S.³ Akira, S.⁴ Flavell, R.A.⁵ Mamula, M.J.⁶ Christensen, S.R.⁷ Shlomchik, M.J.⁸ Viglianti, G.A.⁹ Rifkin, I.R.¹⁰ Marshak-Rothstein, A.¹¹

24
- 0037061453
- Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
- Leadbetter, E.A., I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416:603-607. http://dx.doi.org/10.1038/416603a
- (2002) Nature. , vol.416 , pp. 603-607
- Leadbetter, E.A.¹ Rifkin, I.R.² Hohlbaum, A.M.³ Beaudette, B.C.⁴ Shlomchik, M.J.⁵ Marshak-Rothstein, A.⁶

25
- 51649111684
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- Lenz, G., G.W. Wright, N.C. Emre, H. Kohlhammer, S.S. Dave, R.E. Davis, S. Carty, L.T. Lam, A.L. Shaffer, W. Xiao, et al. 2008. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc. Natl. Acad. Sci. USA. 105:13520-13525. http://dx.doi.org/10.1073/pnas.0804295105
- (2008) Proc. Natl. Acad. Sci. USA. , vol.105 , pp. 13520-13525
- Lenz, G.¹ Wright, G.W.² Emre, N.C.³ Kohlhammer, H.⁴ Dave, S.S.⁵ Davis, R.E.⁶ Carty, S.⁷ Lam, L.T.⁸ Shaffer, A.L.⁹ Xiao, W.¹⁰

26
- 84865167399
- MYD88 somatic mutations in MALT lymphomas
- Li, Z.M., A. Rinaldi, A. Cavalli, A.A. Mensah, M. Ponzoni, R.D. Gascoyne, G. Bhagat, E. Zucca, and F. Bertoni. 2012. MYD88 somatic mutations in MALT lymphomas. Br. J. Haematol. 158:662-664. http://dx.doi.org/10.1111/j.1365-2141.2012.09176.x
- (2012) Br. J. Haematol. , vol.158 , pp. 662-664
- Li, Z.M.¹ Rinaldi, A.² Cavalli, A.³ Mensah, A.A.⁴ Ponzoni, M.⁵ Gascoyne, R.D.⁶ Bhagat, G.⁷ Zucca, E.⁸ Bertoni, F.⁹

27
- 84931266819
- Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide inhibitors of IRAK4
- Lim, J., M.D. Altman, J. Baker, J.D. Brubaker, H. Chen, Y. Chen, T. Fischmann, C. Gibeau, M.A. Kleinschek, E. Leccese, et al. 2015. Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide inhibitors of IRAK4. ACS Med. Chem. Lett. 6:683-688. http://dx.doi.org/10.1021/acsmedchemlett.5b00107
- (2015) ACS Med. Chem. Lett. , vol.6 , pp. 683-688
- Lim, J.¹ Altman, M.D.² Baker, J.³ Brubaker, J.D.⁴ Chen, H.⁵ Chen, Y.⁶ Fischmann, T.⁷ Gibeau, C.⁸ Kleinschek, M.A.⁹ Leccese, E.¹⁰

28
- 33751567260
- IFN regulatory factor 4 and 8 promote Ig light chain κ locus activation in pre-B cell development
- Ma, S., A. Turetsky, L. Trinh, and R. Lu. 2006. IFN regulatory factor 4 and 8 promote Ig light chain κ locus activation in pre-B cell development. J. Immunol. 177:7898-7904. http://dx.doi.org/10.4049/jimmunol.177.11.7898
- (2006) J. Immunol. , vol.177 , pp. 7898-7904
- Ma, S.¹ Turetsky, A.² Trinh, L.³ Lu, R.⁴

29
- 33750369226
- Toll-like receptors in systemic autoimmune disease
- Marshak-Rothstein, A. 2006. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6:823-835. http://dx.doi.org/10.1038/nri1957
- (2006) Nat. Rev. Immunol. , vol.6 , pp. 823-835
- Marshak-Rothstein, A.¹

30
- 84860642907
- Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells
- Matera, G., A. Quirino, A. Giancotti, M.C. Pulicari, L. Rametti, M.L. Rodríguez, M.C. Liberto, and A. Focà. 2012. Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells. BMC Microbiol. 12:68. http://dx.doi.org/10.1186/1471-2180-12-68
- (2012) BMC Microbiol. , vol.12 , pp. 68
- Matera, G.¹ Quirino, A.² Giancotti, A.³ Pulicari, M.C.⁴ Rametti, L.⁵ Rodríguez, M.L.⁶ Liberto, M.C.⁷ Focà, A.⁸

31
- 84935898583
- Potent and selective amidopyrazole inhibitors of IRAK4 that are efficacious in a rodent model of inflammation
- McElroy, W.T., Z. Tan, G. Ho, S. Paliwal, G. Li, W.M. Seganish, D. Tulshian, J. Tata, T.O. Fischmann, C. Sondey, et al. 2015. Potent and selective amidopyrazole inhibitors of IRAK4 that are efficacious in a rodent model of inflammation. ACS Med. Chem. Lett. 6:677-682. http://dx.doi.org/10.1021/acsmedchemlett.5b00106
- (2015) ACS Med. Chem. Lett. , vol.6 , pp. 677-682
- McElroy, W.T.¹ Tan, Z.² Ho, G.³ Paliwal, S.⁴ Li, G.⁵ Seganish, W.M.⁶ Tulshian, D.⁷ Tata, J.⁸ Fischmann, T.O.⁹ Sondey, C.¹⁰

32
- 79551686422
- Oncogenically active MYD88 mutations in human lymphoma
- Ngo, V.N., R.M. Young, R. Schmitz, S. Jhavar, W. Xiao, K.H. Lim, H. Kohlhammer, W. Xu, Y. Yang, H. Zhao, et al. 2011. Oncogenically active MYD88 mutations in human lymphoma. Nature. 470:115-119. http://dx.doi.org/10.1038/nature09671
- (2011) Nature. , vol.470 , pp. 115-119
- Ngo, V.N.¹ Young, R.M.² Schmitz, R.³ Jhavar, S.⁴ Xiao, W.⁵ Lim, K.H.⁶ Kohlhammer, H.⁷ Xu, W.⁸ Yang, Y.⁹ Zhao, H.¹⁰

33
- 84863983181
- MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type
- Pham-Ledard, A., D. Cappellen, F. Martinez, B. Vergier, M. Beylot-Barry, and J.P. Merlio. 2012. MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type. J. Invest. Dermatol. 132:2118-2120. http://dx.doi.org/10.1038/jid.2012.102
- (2012) J. Invest. Dermatol. , vol.132 , pp. 2118-2120
- Pham-Ledard, A.¹ Cappellen, D.² Martinez, F.³ Vergier, B.⁴ Beylot-Barry, M.⁵ Merlio, J.P.⁶

34
- 80051755778
- Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collageninduced arthritis in DBA1J mice
- Pierer, M., U. Wagner, M. Rossol, and S. Ibrahim. 2011. Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collageninduced arthritis in DBA1J mice. PLoS One. 6:e23539. http://dx.doi.org/10.1371/journal.pone.0023539
- (2011) PLoS One. , vol.6 , pp. e23539
- Pierer, M.¹ Wagner, U.² Rossol, M.³ Ibrahim, S.⁴

35
- 79960036578
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- Puente, X.S., M. Pinyol, V. Quesada, L. Conde, G.R. Ordóñez, N. Villamor, G. Escaramis, P. Jares, S. Beà, M. González-Díaz, et al. 2011. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 475:101-105. http://dx.doi.org/10.1038/nature10113
- (2011) Nature. , vol.475 , pp. 101-105
- Puente, X.S.¹ Pinyol, M.² Quesada, V.³ Conde, L.⁴ Ordóñez, G.R.⁵ Villamor, N.⁶ Escaramis, G.⁷ Jares, P.⁸ Beà, S.⁹ González-Díaz, M.¹⁰

36
- 33747133955
- Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation
- Sciammas, R., A.L. Shaffer, J.H. Schatz, H. Zhao, L.M. Staudt, and H. Singh. 2006. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity. 25:225-236. http://dx.doi.org/10.1016/j.immuni.2006.07.009
- (2006) Immunity. , vol.25 , pp. 225-236
- Sciammas, R.¹ Shaffer, A.L.² Schatz, J.H.³ Zhao, H.⁴ Staudt, L.M.⁵ Singh, H.⁶

37
- 84873540049
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- Souers, A.J., J.D. Leverson, E.R. Boghaert, S.L. Ackler, N.D. Catron, J. Chen, B.D. Dayton, H. Ding, S.H. Enschede, W.J. Fairbrother, et al. 2013. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 19:202-208. http://dx.doi.org/10.1038/nm.3048
- (2013) Nat. Med. , vol.19 , pp. 202-208
- Souers, A.J.¹ Leverson, J.D.² Boghaert, E.R.³ Ackler, S.L.⁴ Catron, N.D.⁵ Chen, J.⁶ Dayton, B.D.⁷ Ding, H.⁸ Enschede, S.H.⁹ Fairbrother, W.J.¹⁰

38
- 0037129212
- Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4
- Suzuki, N., S. Suzuki, G.S. Duncan, D.G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 416:750-756. http://dx.doi.org/10.1038/nature736
- (2002) Nature. , vol.416 , pp. 750-756
- Suzuki, N.¹ Suzuki, S.² Duncan, G.S.³ Millar, D.G.⁴ Wada, T.⁵ Mirtsos, C.⁶ Takada, H.⁷ Wakeham, A.⁸ Itie, A.⁹ Li, S.¹⁰

39
- 84865475885
- MYD88 L265P somatic mutation in Waldenström's macroglobulinemia
- Treon, S.P., L. Xu, G. Yang, Y. Zhou, X. Liu, Y. Cao, P. Sheehy, R.J. Manning, C.J. Patterson, C. Tripsas, et al. 2012. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N. Engl. J. Med. 367:826-833. http://dx.doi.org/10.1056/NEJMoa1200710
- (2012) N. Engl. J. Med. , vol.367 , pp. 826-833
- Treon, S.P.¹ Xu, L.² Yang, G.³ Zhou, Y.⁴ Liu, X.⁵ Cao, Y.⁶ Sheehy, P.⁷ Manning, R.J.⁸ Patterson, C.J.⁹ Tripsas, C.¹⁰

40
- 84899096048
- Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4
- Tumey, L.N., D.H. Boschelli, N. Bhagirath, J. Shim, E.A. Murphy, D. Goodwin, E.M. Bennett, M. Wang, L.L. Lin, B. Press, et al. 2014. Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4. Bioorg. Med. Chem. Lett. 24:2066-2072. http://dx.doi.org/10.1016/j.bmcl.2014.03.056
- (2014) Bioorg. Med. Chem. Lett. , vol.24 , pp. 2066-2072
- Tumey, L.N.¹ Boschelli, D.H.² Bhagirath, N.³ Shim, J.⁴ Murphy, E.A.⁵ Goodwin, D.⁶ Bennett, E.M.⁷ Wang, M.⁸ Lin, L.L.⁹ Press, B.¹⁰

41
- 33845231575
- Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeper
- Wang, Z., J. Liu, A. Sudom, M. Ayres, S. Li, H. Wesche, J.P. Powers, and N.P. Walker. 2006. Crystal structures of IRAK-4 kinase in complex with inhibitors: a serine/threonine kinase with tyrosine as a gatekeeper. Structure. 14:1835-1844. http://dx.doi.org/10.1016/j.str.2006.11.001
- (2006) Structure. , vol.14 , pp. 1835-1844
- Wang, Z.¹ Liu, J.² Sudom, A.³ Ayres, M.⁴ Li, S.⁵ Wesche, H.⁶ Powers, J.P.⁷ Walker, N.P.⁸

42
- 70350129230
- IRAK-4 inhibitors for inflammation
- Wang, Z., H. Wesche, T. Stevens, N. Walker, and W.C. Yeh. 2009. IRAK-4 inhibitors for inflammation. Curr. Top. Med. Chem. 9:724-737. http://dx.doi.org/10.2174/156802609789044407
- (2009) Curr. Top. Med. Chem. , vol.9 , pp. 724-737
- Wang, Z.¹ Wesche, H.² Stevens, T.³ Walker, N.⁴ Yeh, W.C.⁵

43
- 84938994998
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
- Wilson, W.H., R.M. Young, R. Schmitz, Y. Yang, S. Pittaluga, G. Wright, C.J. Lih, P.M. Williams, A.L. Shaffer, J. Gerecitano, et al. 2015. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat. Med. 21:922-926. http://dx.doi.org/10.1038/nm.3884
- (2015) Nat. Med. , vol.21 , pp. 922-926
- Wilson, W.H.¹ Young, R.M.² Schmitz, R.³ Yang, Y.⁴ Pittaluga, S.⁵ Wright, G.⁶ Lih, C.J.⁷ Williams, P.M.⁸ Shaffer, A.L.⁹ Gerecitano, J.¹⁰

44
- 84862152044
- Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma
- Yang, Y., A.L. Shaffer III, N.C. Emre, M. Ceribelli, M. Zhang, G. Wright, W. Xiao, J. Powell, J. Platig, H. Kohlhammer, et al. 2012. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell. 21:723-737. http://dx.doi.org/10.1016/j.ccr.2012.05.024
- (2012) Cancer Cell. , vol.21 , pp. 723-737
- Yang, Y.¹ Shaffer, A.L.² Emre, N.C.³ Ceribelli, M.⁴ Zhang, M.⁵ Wright, G.⁶ Xiao, W.⁷ Powell, J.⁸ Platig, J.⁹ Kohlhammer, H.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.